Because Time Matters
The NeuroBlate® System is a minimally invasive robotically controlled laser thermotherapy that uses MRI-guided laser light to ablate (destroy) unwanted tissue in the brain where the lesion, or abnormal tissue originates.
Explore what to expect before, during, and after ablation with the NeuroBlate System.
Monteris devices are used by neurosurgeons, which allows them to hold the patient’s head steady while in an MRI machine and during brain surgery, to allow minimally invasive and stable access for brain probes, and to heat and destroy targeted tissue. Patients must be able to undergo MRI exposure. All brain surgeries carry risk. Possible adverse events include, but are not limited to, bleeding, edema, unintended major brain tissue damage, and permanent neurological deficits. Discuss with your physician the potential benefits and risks.
- Wilson TA, Karajannis MA, and Harter DH. Glioblastoma multiforme: State of the art and future therapeutics. Surg Neurol Int. 2014 May 8;5:64.
- Mohammadi, AM and Schroeder, JL. Laser interstitial thermal therapy in treatment of brain tumors – the NeuroBlate® System. Expert Review of Medical Devices 2014 11:2, 109-119.
- Sloan AE, Ahluwalia MS, Valerio-Pascua J, et al. Results of the NeuroBlate® System first-in-humans Phase I clinical trial for recurrent glioblastoma: clinical article. J Neurosurg. 2013 Jun;118(6):1202-19.
- Carpentier A, McNichols RJ, Stafford RJ, et al. Laser thermal therapy: real-time MRI-guided and computer- controlled procedures for metastatic brain tumors. Lasers Surg Med. 2011 Dec;43(10):943-50.